Generation Bio Co (NAS:GBIO)
$ 2.64 -0.13 (-4.69%) Market Cap: 176.20 Mil Enterprise Value: 53.21 Mil PE Ratio: 0 PB Ratio: 1.61 GF Score: 34/100

Generation Bio Co at Jefferies Gene Therapy/Editing Summit (Virtual) Transcript

Oct 27, 2021 / 09:00PM GMT
Release Date Price: $20.52 (-4.34%)
Eun Yang
(Trades, Portfolio) LLC - Analyst

Good afternoon, everyone. I am hosting a fireside chat with Geoff McDonough, CEO of Generation Bio. Thank you, Geoff, for your participation in the discussion [in advance]. As you may know, many of you know, Generation Bio is working on potentially transformative gene therapy programs.

So before we go into the Q&As with Geoff -- Geoff, can you give us an overview of the platform as well as the key differentiation from your platform compared to other gene therapy companies?

Geoff McDonough
Generation Bio Co. - President and CEO

Yeah, for sure. First, Eun, thank you for the chance to be here with you. It's always fun to chat and I'm especially excited about what we're up to here at Generation Bio. This is

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot